|
Andrew Ment’s practice focuses on mergers and acquisitions and private equity transactions. Mr. Ment’s M&A experience includes public and private acquisitions and divestitures, leveraged buy-outs, “going private” transactions and joint ventures. Mr. Ment also practices in the area of corporate finance, where his experience includes syndicated lending, royalty sales & financings, registered offerings, and private placements.
Representative Matters
- Forest Laboratories, Inc. in its $1.2 billion acquisition of Clinical Data, Inc.
- Procter & Gamble in the $3.1 billion sale of its pharmaceuticals business to Warner-Chilcott.
- Snow Phipps Group in its acquisitions of ITSolutions and the IT services business of NetStar-1, Inc.
- Northwestern University in the sale of a portion of its worldwide royalty interest in Lyrica for $700 million.
- GSI Holdings Corp. and Charlesbank Capital Partners in the acquisition of a majority interest in GSI Holdings Corp. by Centerbridge Capital Partners.
- Oregon Steel Mills, Inc. in its $2.3 billion merger into Evraz Group S.A.
- Abbott Laboratories in its $3.7 billion acquisition of Kos Pharmaceuticals, Inc.
- Kerr-McGee Corporation in its $18 billion merger into Anadarko Petroleum Corporation.
- Pfizer Inc. in its acquisition of Rinat Neuroscience Corp.
Previous Experience
- Economic Consulting Services Inc., Staff Economist (1993-1995)
|